ã€ãŒã©ã€ãªãªãŒã»ã¢ã³ãã»ã«ã³ãããŒã¯ãäžçäžã§äººéçšå»è¬åã®çºèŠãéçºã販売ãè¡ã£ãŠããŸããå瀟ã¯ãé床ã®äœè¡ç³ççšã® Baqsimiãç³å°¿ç
çšã® BasaglarãHumalogãHumalog Mix 75/25ãHumalog U-100ãHumalog U-200ãHumalog Mix 50/50ãã€ã³ã¹ãªã³ ãªã¹ãããã€ã³ã¹ãªã³ ãªã¹ãã ããã¿ãã³ãã€ã³ã¹ãªã³ ãªã¹ãã ããã¯ã¹ 75/25ãHumulinãHumulin 70/30ãHumulin NãHumulin RãHumulin U-500ãLyumjevã2 åç³å°¿ç
çšã® JardianceãTrajentaãTrulicity ãæäŸããŠããŸããå瀟ã¯ãéå°çްèèºãã (NSCLC) ããã³æªæ§èžèäžç®è
«çšã® Alimta ãæäŸããŠããŸãã転移æ§èãããèé£éæ¥åéšè
ºããã転移æ§éå°çްèèºããã転移æ§å€§è
žãããè现èããã«ã¯Cyramzaã倧è
žãããããŸããŸãªé é žéšããã«ã¯Erbituxã転移æ§éå°çްèèºãããç²ç¶è
ºé«æ§ãããç²ç¶è
ºããã«ã¯Retevmoãåçºæ§ãŸãã¯é£æ²»æ§ã®å€å
žçããžãã³ãªã³ãè
«ããã³éæå¹³äžç®éå°çްèèºããã«ã¯TyvytãHR+ããã³HER2-転移æ§ä¹³ããã«ã¯VerzenioãæäŸããŠããŸããé¢ç¯ãªãŠããã«ã¯Olumiantãå°åžžæ§ä¹Ÿç¬ãä¹Ÿç¬æ§é¢ç¯çãåŒ·çŽæ§èæ€çãéæŸå°ç·åŠç軞æ§èæ€é¢ç¯çã«ã¯TaltzãæäŸããŠããŸããå瀟ã¯ããã€ç
ãç³å°¿ç
æ§æ«æ¢¢ç¥çµé害æ§çŒçãå
šè¬æ§äžå®é害ãç·ç¶çççãæ
¢æ§çéªšæ Œçã®æ²»çè¬ãšããŠã·ã³ãã«ã¿ãçé çäºé²ããã³çŸ€çºæ§é çã®æ²»çè¬ãšã ã¬ãªãã£ãçé çã®æ²»çè¬ã¬ã€ããŠãçµ±å倱調çã忥µæ§Iåé害ã忥µæ§éå®³ç¶æçæ³ã®æ²»çè¬ãžãã¬ããµãæäŸããŠããããŸããCOVID-19ã®æ²»çè¬ãšããŠãã ã©ãããããšãšãã»ããããåèµ·äžå
šããã³åç«è
ºè¥å€§çã®æ²»çè¬ã·ã¢ãªã¹ã骚ç²é¬çã®æ²»çè¬ãã©ã«ããªãæäŸããŠãããã€ãŒã©ã€ãªãªãŒã»ã¢ã³ãã»ã«ã³ãããŒã¯ãã€ã³ãµã€ãã»ã³ãŒãã¬ãŒã·ã§ã³ããã¡ã€ã¶ãŒç€ŸãAC Immune SAãã»ã³ãã¬ãã·ãªã³ã»ã»ã©ãã¥ãŒãã£ã¯ã¹ã»ã³ãŒãã¬ãŒã·ã§ã³ãImmuNextãInc.ãAvidity BiosciencesãInc.ãAbCellera Biologics Inc.ãJunshi BiosciencesãMiNA Therapeutics LimitedãVerge GenomicsããããŒã»ã¢ã«ããã€ããŒç ç©¶æãããã³ã¯ã ã¯ã¯ããã»ãã€ãªãµã€ãšã³ã¹ãåäžã«ãããŸããå瀟㯠1876 幎ã«èšç«ãããã€ã³ãã£ã¢ãå·ã€ã³ãã£ã¢ãããªã¹ã«æ¬ç€Ÿã眮ããŠããŸãã